The ROE as of December 2024 (TTM) for Senti Biosciences, Inc. (SNTI) is -154.84%

According to Senti Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -154.84%. This represents a change of 142.49% compared to the average of -63.85% of the last 4 quarters.

Senti Biosciences, Inc. (SNTI) Historical ROE (quarterly & annually)

How has SNTI ROE performed in the past?

The mean historical ROE of Senti Biosciences, Inc. over the last ten years is -43.78%. The current -154.84% ROE has changed 253.65% with respect to the historical average. Over the past ten years (40 quarters), SNTI's ROE was at its highest in in the December 2021 quarter at 9.78%. The ROE was at its lowest in in the September 2024 quarter at -180.48%.

Senti Biosciences, Inc. (SNTI) ROE by Quarter and Year

Discovering the peaks and valleys of Senti Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Senti Biosciences, Inc. (SNTI) Average ROE

How has SNTI ROE performed in the past?

The current ROE of Senti Biosciences, Inc. (SNTI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Senti Biosciences, Inc. (SNTI) ROE vs. Peers

How is SNTI’s ROE compared to its peers?

Senti Biosciences, Inc.’s ROE is less than ZIVO Bioscience, Inc. (618.61%), greater than Cadrenal Therapeutics, Inc. Common Stock (-142.95%), less than Foghorn Therapeutics Inc. (167.93%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than SAB Biotherapeutics, Inc. (-94.37%), greater than Cingulate Inc. (-113174.53%), less than Bellicum Pharmaceuticals, Inc. (33.22%), greater than Hillstream BioPharma, Inc. (-172.28%), greater than Lipella Pharmaceuticals Inc. (-107557.27%), less than Fennec Pharmaceuticals Inc. (31.99%), greater than Monopar Therapeutics Inc. (-21731.73%), greater than Applied Molecular Transport Inc. (-131.59%), greater than Neoleukin Therapeutics, Inc. (-8.54%), greater than SAB Biotherapeutics, Inc. (-94.37%), less than Connect Biopharma Holdings Limited (7.21%), greater than Tyra Biosciences, Inc. (-25.14%), greater than RAPT Therapeutics, Inc. (-89.09%), greater than Xilio Therapeutics, Inc. (-214.74%), greater than Mineralys Therapeutics, Inc. (-55.92%),

Build a custom stock screener for Senti Biosciences, Inc. (SNTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Senti Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Senti Biosciences, Inc. (SNTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Senti Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.